Leads Biolabs Maintains Stable Share Base in March 2026; Confirms Public-Float Compliance

Bulletin Express04-01

Nanjing Leads Biolabs Co., Ltd. reported no movements in either authorised or issued share capital for the month ended 31 March 2026, according to its latest monthly return filed with Hong Kong Exchanges and Clearing Limited.

Authorised/registered share capital remained unchanged at RMB 198.89 million, comprising: • 153.28 million H-shares listed in Hong Kong with a nominal value of RMB 1 each. • 45.61 million unlisted domestic shares, also at RMB 1 par value.

Issued share capital mirrored the authorised structure and likewise showed no change during the month: • 153.28 million H-shares in issue and nil treasury shares. • 45.61 million unlisted shares in issue.

The company confirmed that as at 31 March 2026 the applicable minimum public-float threshold—25 % of the total issued H-shares—was satisfied.

No share options, warrants, convertible securities, or other agreements that could lead to equity dilution were outstanding or executed during the period, and no treasury-share transactions occurred.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1164371785?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-01 11:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1164371785","market":"us","top_or_hot":-1,"title":"Leads Biolabs Maintains Stable Share Base in March 2026; Confirms Public-Float Compliance","media":"Bulletin Express","content":"<p>Nanjing Leads Biolabs Co., Ltd. reported no movements in either authorised or issued share capital for the month ended 31 March 2026, according to its latest monthly return filed with Hong Kong Exchanges and Clearing Limited.</p>\n<p>Authorised/registered share capital remained unchanged at RMB 198.89 million, comprising:\n• 153.28 million H-shares listed in Hong Kong with a nominal value of RMB 1 each.  \n• 45.61 million unlisted domestic shares, also at RMB 1 par value.</p>\n<p>Issued share capital mirrored the authorised structure and likewise showed no change during the month:\n• 153.28 million H-shares in issue and nil treasury shares.  \n• 45.61 million unlisted shares in issue.</p>\n<p>The company confirmed that as at 31 March 2026 the applicable minimum public-float threshold—25 % of the total issued H-shares—was satisfied.</p>\n<p>No share options, warrants, convertible securities, or other agreements that could lead to equity dilution were outstanding or executed during the period, and no treasury-share transactions occurred.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Leads Biolabs Maintains Stable Share Base in March 2026; Confirms Public-Float Compliance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLeads Biolabs Maintains Stable Share Base in March 2026; Confirms Public-Float Compliance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-01 11:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nanjing Leads Biolabs Co., Ltd. reported no movements in either authorised or issued share capital for the month ended 31 March 2026, according to its latest monthly return filed with Hong Kong Exchanges and Clearing Limited.</p>\n<p>Authorised/registered share capital remained unchanged at RMB 198.89 million, comprising:\n• 153.28 million H-shares listed in Hong Kong with a nominal value of RMB 1 each.  \n• 45.61 million unlisted domestic shares, also at RMB 1 par value.</p>\n<p>Issued share capital mirrored the authorised structure and likewise showed no change during the month:\n• 153.28 million H-shares in issue and nil treasury shares.  \n• 45.61 million unlisted shares in issue.</p>\n<p>The company confirmed that as at 31 March 2026 the applicable minimum public-float threshold—25 % of the total issued H-shares—was satisfied.</p>\n<p>No share options, warrants, convertible securities, or other agreements that could lead to equity dilution were outstanding or executed during the period, and no treasury-share transactions occurred.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09887","symbol_name":"维立志博-B","start_time":0,"source_url":"","article_id":"1164371785","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1164371785","pubTimestamp":1775012798,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Nanjing Leads Biolabs Co., Ltd. reported no movements in either authorised or issued share capital for the month ended 31 March 2026, according to its latest monthly return filed with Hong Kong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09887":"维立志博-B"},"translate_title":"Leads Biolabs在2026年3月保持稳定的份额基础；确认公众持股合规性","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09887":1},"content_text":"Nanjing Leads Biolabs Co., Ltd. reported no movements in either authorised or issued share capital for the month ended 31 March 2026, according to its latest monthly return filed with Hong Kong Exchanges and Clearing Limited.\nAuthorised/registered share capital remained unchanged at RMB 198.89 million, comprising:\n• 153.28 million H-shares listed in Hong Kong with a nominal value of RMB 1 each.  \n• 45.61 million unlisted domestic shares, also at RMB 1 par value.\nIssued share capital mirrored the authorised structure and likewise showed no change during the month:\n• 153.28 million H-shares in issue and nil treasury shares.  \n• 45.61 million unlisted shares in issue.\nThe company confirmed that as at 31 March 2026 the applicable minimum public-float threshold—25 % of the total issued H-shares—was satisfied.\nNo share options, warrants, convertible securities, or other agreements that could lead to equity dilution were outstanding or executed during the period, and no treasury-share transactions occurred.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1164371785","isCrawlerRequest":true}